Breast Cancer News

A program that combined physical activity with psychological therapy appeared to improve mental and physical health, as well as quality of life, among patients with cancer and survivors.

New 3D imaging technology developed at University of Michigan enables real-time measurement of radiation treatment, enhancing precision and potentially minimizing off-target effects.

Clinical trials performed within the NCI’s National Clinical Trials Network during the past 40 years prolonged the lives of patients with cancer by at least 14.2 million life-years, according to a study in Journal of Clinical Oncology.

The oncolytic virus talimogene laherparepvec combined with neoadjuvant chemotherapy appeared safe and effective for women with early-stage triple-negative breast cancer, according to phase 2 study results published in Nature Medicine.

Among patients with solid tumors, septic shock was associated with a 69.4% 28-day mortality rate, according to a study published in CHEST.

Researchers at Cold Spring Harbor Laboratory have developed software that correctly deduces continental ancestry from tumor DNA and RNA.

The FDA announced several regulatory actions the past few weeks.

The FDA expanded the approval of sacituzumab govitecan-hziy to include treatment of certain patients with hormone receptor-positive disease.

Members of sex and gender minority groups experienced longer times from symptom onset to breast cancer diagnosis compared with a cohort of cisgender heterosexuals, according to study results published in JAMA Oncology.

Talazoparib appeared effective among certain patients with advanced, PALB2-mutated breast cancer, according to study results published in Nature Cancer.